Apart from the cytokines mentioned above, IL-12 seems to be an ideal alternative for immunotherapy-based therapies that might slow tumor development by triggering efficient anti-tumor immune responses and cytotoxic NK and CD8+ T cells that target and destroy tumor cells [149]. Here, CD8A is linked to neoplasm.